Susquehanna International »

Bioline Rx shares owned by Susquehanna International

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-09-30 $76k 20k 3.78
2025-06-30 $51k 11k 4.57

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
UnitedHealth (UNH)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)

View all positions for Susquehanna International

Top funds holding Bioline Rx

Susquehanna International
Citadel Advisors
UBS Group
Rhumbline Advisers
Wells Fargo & Company
Nemes Rush Group
Goss Wealth Management
Simplex Trading
Tower Research Capital
Rockefeller Capital Management
SBI Securities
Danske Bank A/s
Advisor Group Holdings

View all funds holding Bioline Rx